Kirr Marbach & Co. LLC IN Grows Stock Holdings in ICU Medical, Inc. (NASDAQ:ICUI)

Kirr Marbach & Co. LLC IN raised its position in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 63.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 35,870 shares of the medical instruments supplier's stock after purchasing an additional 13,951 shares during the period. Kirr Marbach & Co. LLC IN owned approximately 0.15% of ICU Medical worth $4,981,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Harvest Fund Management Co. Ltd acquired a new position in ICU Medical during the fourth quarter valued at approximately $33,000. Quarry LP increased its holdings in shares of ICU Medical by 764.3% during the fourth quarter. Quarry LP now owns 242 shares of the medical instruments supplier's stock worth $38,000 after buying an additional 214 shares in the last quarter. Murphy & Mullick Capital Management Corp acquired a new position in shares of ICU Medical during the fourth quarter worth $52,000. Venturi Wealth Management LLC increased its holdings in shares of ICU Medical by 64.0% during the fourth quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier's stock worth $82,000 after buying an additional 206 shares in the last quarter. Finally, Russell Investments Group Ltd. increased its holdings in shares of ICU Medical by 88.8% during the fourth quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier's stock worth $99,000 after buying an additional 300 shares in the last quarter. 96.10% of the stock is currently owned by institutional investors and hedge funds.

ICU Medical Trading Up 0.9%

NASDAQ ICUI traded up $1.14 on Friday, reaching $131.82. The company had a trading volume of 993,495 shares, compared to its average volume of 272,032. The firm has a market cap of $3.24 billion, a price-to-earnings ratio of -34.42 and a beta of 0.88. ICU Medical, Inc. has a fifty-two week low of $114.82 and a fifty-two week high of $196.26. The business has a 50 day moving average of $134.09 and a two-hundred day moving average of $146.68. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.59 and a quick ratio of 1.52.

ICU Medical (NASDAQ:ICUI - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share for the quarter, beating analysts' consensus estimates of $1.23 by $0.49. ICU Medical had a positive return on equity of 6.75% and a negative net margin of 3.87%. The business had revenue of $599.49 million during the quarter, compared to the consensus estimate of $574.15 million. During the same period in the prior year, the business posted $0.96 earnings per share. ICU Medical's quarterly revenue was up 6.7% on a year-over-year basis. Analysts forecast that ICU Medical, Inc. will post 4.11 EPS for the current year.

Analyst Ratings Changes

Several brokerages have recently issued reports on ICUI. Needham & Company LLC reiterated a "hold" rating on shares of ICU Medical in a report on Tuesday, April 8th. KeyCorp lowered their price target on shares of ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a report on Monday, April 21st. Wall Street Zen upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a report on Sunday, May 18th. Finally, Raymond James Financial lowered their price target on shares of ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating for the company in a report on Friday, May 9th. One investment analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, ICU Medical presently has an average rating of "Buy" and a consensus target price of $192.67.

Insider Transactions at ICU Medical

In other ICU Medical news, Director Elisha W. Finney sold 600 shares of the stock in a transaction dated Monday, May 19th. The shares were sold at an average price of $138.92, for a total value of $83,352.00. Following the completion of the sale, the director now owns 3,252 shares in the company, valued at approximately $451,767.84. This trade represents a 15.58% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Ben Sousa sold 2,000 shares of the stock in a transaction dated Thursday, May 15th. The shares were sold at an average price of $137.36, for a total transaction of $274,720.00. Following the completion of the sale, the insider now owns 479 shares of the company's stock, valued at approximately $65,795.44. This trade represents a 80.68% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 36,097 shares of company stock valued at $4,860,156 in the last 90 days. 1.50% of the stock is currently owned by corporate insiders.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.